Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
Betsy T. Kren(Minneapolis VA Health Care System), Janeen H. Trembley(University of Minnesota)
Cited by 70
Related Papers
Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice
|Journal of Clinical Investigation|2009|105